BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 1545137)

  • 1. Lamellar body secretory response to barrier disruption.
    Menon GK; Feingold KR; Elias PM
    J Invest Dermatol; 1992 Mar; 98(3):279-89. PubMed ID: 1545137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The morphologic changes in lamellar bodies and intercorneocyte lipids after tape stripping and occlusion with a water vapor-impermeable membrane.
    Jiang S; Koo SW; Lee SH
    Arch Dermatol Res; 1998 Mar; 290(3):145-51. PubMed ID: 9558490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for the barrier abnormality following inhibition of HMG CoA reductase in murine epidermis.
    Menon GK; Feingold KR; Mao-Qiang M; Schaude M; Elias PM
    J Invest Dermatol; 1992 Feb; 98(2):209-19. PubMed ID: 1732385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization of calcium in murine epidermis following disruption and repair of the permeability barrier.
    Menon GK; Elias PM; Lee SH; Feingold KR
    Cell Tissue Res; 1992 Dec; 270(3):503-12. PubMed ID: 1486603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional and structural changes of the epidermal barrier induced by various types of insults in hairless mice.
    Ahn SK; Jiang SJ; Hwang SM; Choi EH; Lee JS; Lee SH
    Arch Dermatol Res; 2001 Jun; 293(6):308-18. PubMed ID: 11480591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinate assembly of lipids and enzyme proteins into epidermal lamellar bodies.
    Rassner U; Feingold KR; Crumrine DA; Elias PM
    Tissue Cell; 1999 Oct; 31(5):489-98. PubMed ID: 10612259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acids are required for epidermal permeability barrier function.
    Mao-Qiang M; Elias PM; Feingold KR
    J Clin Invest; 1993 Aug; 92(2):791-8. PubMed ID: 8102380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective obliteration of the epidermal calcium gradient leads to enhanced lamellar body secretion.
    Menon GK; Price LF; Bommannan B; Elias PM; Feingold KR
    J Invest Dermatol; 1994 May; 102(5):789-95. PubMed ID: 8176264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities.
    Kao JS; Fluhr JW; Man MQ; Fowler AJ; Hachem JP; Crumrine D; Ahn SK; Brown BE; Elias PM; Feingold KR
    J Invest Dermatol; 2003 Mar; 120(3):456-64. PubMed ID: 12603860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aged epidermal permeability barrier. Structural, functional, and lipid biochemical abnormalities in humans and a senescent murine model.
    Ghadially R; Brown BE; Sequeira-Martin SM; Feingold KR; Elias PM
    J Clin Invest; 1995 May; 95(5):2281-90. PubMed ID: 7738193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingolipids are required for mammalian epidermal barrier function. Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation.
    Holleran WM; Man MQ; Gao WN; Menon GK; Elias PM; Feingold KR
    J Clin Invest; 1991 Oct; 88(4):1338-45. PubMed ID: 1918384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural and biochemical basis for the UVB-induced alterations in epidermal barrier function.
    Holleran WM; Uchida Y; Halkier-Sorensen L; Haratake A; Hara M; Epstein JH; Elias PM
    Photodermatol Photoimmunol Photomed; 1997 Aug; 13(4):117-28. PubMed ID: 9453079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-hydroxyceramides are required for corneocyte lipid envelope (CLE) formation and normal epidermal permeability barrier function.
    Behne M; Uchida Y; Seki T; de Montellano PO; Elias PM; Holleran WM
    J Invest Dermatol; 2000 Jan; 114(1):185-92. PubMed ID: 10620136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stratum corneum structure and function correlates with phenotype in psoriasis.
    Ghadially R; Reed JT; Elias PM
    J Invest Dermatol; 1996 Oct; 107(4):558-64. PubMed ID: 8823361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of the permeability barrier abnormality in epidermolytic hyperkeratosis.
    Schmuth M; Yosipovitch G; Williams ML; Weber F; Hintner H; Ortiz-Urda S; Rappersberger K; Crumrine D; Feingold KR; Elias PM
    J Invest Dermatol; 2001 Oct; 117(4):837-47. PubMed ID: 11676820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute barrier perturbation abolishes the Ca2+ and K+ gradients in murine epidermis: quantitative measurement using PIXE.
    Mauro T; Bench G; Sidderas-Haddad E; Feingold K; Elias P; Cullander C
    J Invest Dermatol; 1998 Dec; 111(6):1198-201. PubMed ID: 9856840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute skin barrier disruption alters the secretion of lamellar bodies via the multilayered expression of ABCA12.
    Teramura T; Nomura T
    J Dermatol Sci; 2020 Oct; 100(1):50-57. PubMed ID: 32873425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secretory granular cell: the outermost granular cell as a specialized secretory cell.
    Elias PM; Cullander C; Mauro T; Rassner U; Kömüves L; Brown BE; Menon GK
    J Investig Dermatol Symp Proc; 1998 Aug; 3(2):87-100. PubMed ID: 9734820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transepidermal water loss: the signal for recovery of barrier structure and function.
    Grubauer G; Elias PM; Feingold KR
    J Lipid Res; 1989 Mar; 30(3):323-33. PubMed ID: 2723540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The permeability barrier in mammalian epidermis.
    Elias PM; Friend DS
    J Cell Biol; 1975 Apr; 65(1):180-91. PubMed ID: 1127009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.